Jackilyn Davis v. HHS - Tdap, Guillain- Barre Syndrome (GBS) and acute inflammatory demyelinating polyneuropathy (AIDP) (2021)
Case summary [AI summaries can sometimes make mistakes]
Jackilyn Davis filed a petition for compensation under the National Vaccine Injury Program on June 19, 2020. Ms.
Davis alleged that she suffered from Guillain-Barre Syndrome (GBS) and acute inflammatory demyelinating polyneuropathy (AIDP) as a result of receiving a Tdap vaccine on April 20, 2019. The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Ms.
Davis's GBS or any other injury. The parties, maintaining their respective positions, reached a stipulation to settle the case.
Under the terms of the stipulation, the respondent agreed to pay Ms. Davis a lump sum of $100,000.00, payable by check to the petitioner.
This amount is intended to compensate for all damages available under the Vaccine Act. Special Master Thomas L.
Gowen issued a decision on the stipulation on November 23, 2021, and judgment was entered in accordance with the stipulation. The public decision does not describe the specific onset of symptoms, medical tests, treatments, or expert witnesses.
Petitioner was represented by Emily Ashe of Anapol Weiss, and respondent was represented by Terrence Mangan of the U.S. Department of Justice.
Theory of causation
Petitioner Jackilyn Davis alleged that a Tdap vaccine administered on April 20, 2019, caused her to suffer from Guillain-Barre Syndrome (GBS) and acute inflammatory demyelinating polyneuropathy (AIDP). The respondent denied causation. The parties reached a stipulation for settlement, agreeing to an award of $100,000.00. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury. The decision was issued by Special Master Thomas L. Gowen on November 23, 2021. Petitioner's counsel was Emily Ashe, and respondent's counsel was Terrence Mangan.
Source PDFs
USCOURTS-cofc-1_20-vv-00732